Browse diseases

…Objectives Achieving durable remission in systemic lupus erythematosus (SLE) remains challenging and unpredictable due to clinical het…

…and elevated anti-thyroid antibodies levels are quite common in SLE, but they do not always occur in the same patient and may be as…

…ctives Rituximab (RTX) is an established therapy for refractory Systemic Lupus Erythematosus (SLE), but its use raises concerns about infection risk and hyp…

…cy and associated risk factors are scarce in the Latin American SLE population. A better understanding of PP manifestations in this…

…for refractory thrombocytopenia.Conclusions Thrombocytopenia in SLE remains relatively common. Its reported association with severe…

…Objectives Long-term follow-up of systemic lupus erythematosus (SLE) provides valuable insight into the natural history of dis…

…G can trigger severe complement-mediated hemolysis in high-risk SLE/APS patients. Complement inhibition may represent a novel thera…

…erative diseases.Results The patient was diagnosed with SLE and Sjögren’s syndrome in October 2024, during his first admission based on the presen…

…Objectives Introduction Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease driven by multiple …

…Objectives Lupus nephritis (LN) is a serious complication of systemic lupus erythematosus …

…Objectives Systemic lupus erythematosus (SLE) and systemic sclerosis (SSc) are distinct connective tiss…

… lupus serositis. First, the domain definition and scope in the SLE clinical trial context were defined. Potentially suitable measu…